AMANDA DIFFIN: Open Payments
NPI 1710547385 · LEOMINSTER, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$520 in 24 payments from 15 companies in 2025. Trend: 2023 $132 · 2024 $312 · 2025 $520
Food & beverage: $520
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 6 | $111 |
| Lilly USA, LLC | 3 | $58 |
| Novo Nordisk Inc | 2 | $40 |
| Exact Sciences Corporation | 2 | $38 |
| Madrigal Pharmaceuticals | 1 | $38 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $30 |
| Astellas Pharma US Inc | 1 | $26 |
| Janssen Pharmaceuticals, Inc | 1 | $26 |
| GlaxoSmithKline, LLC. | 1 | $25 |
| Hologic Sales and Service, LLC | 1 | $24 |
Products named: VRAYLAR, The Cologuard Plus Collection Kit, REZDIFFRA, MOUNJARO, CAPLYTA, Veozah, SPRAVATO, SHINGRIX.
Industry payments across MA — which companies pay providers there.
